1. Ashizawa T, Epstein HF. Ethnic distribution of myotonic dystrophy gene. Lancet. 1991. 338:642–643.
2. Mathieu J, Allard P, Potvin L, Prevost C, Begin P. A 10 year study of mortality in a cohort of patients with myotonic dystrophy. Neurology. 1999. 52:1658–1662.
3. Finsterer J, Stollberger C, Blazek G, Kunafer M, Prager E. Cardiac involvement over 10 years in myotonic and Becker muscular dystrophy and mitochondrial disorder. Int J Cardiol. 2007. 119:176–184.
4. Kang WK, Ku DH, Shin SH, Jeong YC, Jeon ES, Park JH. A case of myotonic dystrophy with prolonged atrial flutter. Korean Circ J. 1989. 19:770–775.
5. Bhakta D, Lowe MR, Groh WJ. Prevalence of structural cardiac abnormalities in patients with myotonic dystrophy type I. Am Heart J. 2004. 147:224–227.
6. Nguyen HH, Wolfe JT 3rd, Holmes DR Jr, Edwards WD. Pathology of the cardiac conduction system in myotonic dystrophy: a study of 12 cases. J Am Coll Cardiol. 1988. 11:662–671.
7. Groh WJ, Groh MR, Saha C, et al. Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1. N Engl J Med. 2008. 358:2688–2697.
8. Phillips MF, Harper PS. Cardiac disease in myotonic dystrophy. Cardiovasc Res. 1997. 33:13–22.
9. Sa MI, Cabral S, Costa PD, Coelho T, Freitas M, Gomes JL. Ambulatory electrocardiographic monitoring in type 1 myotonic dystrophy. Rev Port Cardiol. 2007. 26:745–753.
10. Gregoratos G, Abrams J, Epstein AE, et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation. 2002. 106:2145–2161.